I'm a little confused as to the concern. You suggest it could bind to the wrong enzyme, however when Xanamem is administered, the tracer see's a difference. It would be safe to hypothesise that this is likely a cause and effect and not just a coincidence that the tracer is binding to a random enzyme at the same time Xanamem is or isn't administered?
Target Occupancy Study (TOS), page-15
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ACW (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.7¢ |
Change
-0.002(5.13%) |
Mkt cap ! $100.3M | |||
| Open | High | Low | Value | Volume |
| 3.7¢ | 3.9¢ | 3.7¢ | $145.2K | 3.906M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 3271721 | 3.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.7¢ | 125725 | 3 |
View Market Depth
| Last trade - 15.37pm 12/09/2024 (20 minute delay) ? |
| ACW (ASX) Chart |